TI-RADS · Tireoide
Sistemas/Tireoide

TI-RADS ACR Thyroid Imaging Reporting and Data System

vigente

Point based ultrasound risk stratification of thyroid nodules across five feature categories, mapping a total score to a TR level and to biopsy or follow up by size.

Índice de referência, não é suporte à decisão clínica. O RadCommons apresenta conteúdo de referência reescrito a partir de critérios publicados e com link para a fonte primária. Confira sempre a publicação primária vigente. Não é um dispositivo médico nem substitui o julgamento clínico. O radiologista responsável pelo laudo permanece o autor e o responsável.
Escala de categorias
TR1TR2TR3TR4TR5

As figuras e tabelas estão na fonte primária. Abrir a fonte. O RadCommons reescreve e cita, não reproduz figuras protegidas por direitos autorais.

Procedência e vigência

Órgão emissor
American College of Radiology
Versão
2017
Ano
2017
Família
léxico
Tipo de lógica
score
Modalidade
US
Fonte primária
ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee · doi:10.1016/j.jacr.2017.01.046
Última verificação
2026-07-24
Última checagem
2026-08-12

Lógica de decisão

Forma estruturada (score). Uma futura calculadora a lê; as categorias abaixo são a superfície legível.

The score selects TR1-TR5; maximum nodule size then selects no action, scheduled ultrasound follow-up, or FNA. Previously biopsied and PET-avid nodules require the documented exceptions.

Mostrar a lógica estruturada (JSON)
{
  "applicability": {
    "use_for": "Risk stratification and size-based management of thyroid nodules characterized on ultrasound.",
    "management_exceptions": [
      "previously_biopsied_nodule",
      "PET_avid_nodule",
      "known_thyroid_malignancy"
    ]
  },
  "feature_groups": [
    {
      "id": "composition",
      "selection": "choose_one",
      "options": [
        {
          "id": "cystic_or_almost_completely_cystic",
          "points": 0
        },
        {
          "id": "spongiform",
          "points": 0,
          "stop_scoring_other_groups": true
        },
        {
          "id": "mixed_cystic_and_solid",
          "points": 1
        },
        {
          "id": "solid_or_almost_completely_solid",
          "points": 2
        },
        {
          "id": "cannot_determine_due_to_calcification",
          "points": 2
        }
      ]
    },
    {
      "id": "echogenicity",
      "selection": "choose_one",
      "options": [
        {
          "id": "anechoic",
          "points": 0
        },
        {
          "id": "hyperechoic_or_isoechoic",
          "points": 1
        },
        {
          "id": "hypoechoic",
          "points": 2
        },
        {
          "id": "very_hypoechoic",
          "points": 3
        },
        {
          "id": "cannot_determine",
          "points": 1
        }
      ]
    },
    {
      "id": "shape",
      "selection": "choose_one",
      "options": [
        {
          "id": "wider_than_tall",
          "points": 0
        },
        {
          "id": "taller_than_wide",
          "points": 3
        }
      ]
    },
    {
      "id": "margin",
      "selection": "choose_one",
      "options": [
        {
          "id": "smooth",
          "points": 0
        },
        {
          "id": "ill_defined",
          "points": 0
        },
        {
          "id": "lobulated_or_irregular",
          "points": 2
        },
        {
          "id": "extrathyroidal_extension",
          "points": 3,
          "caveat": "Obvious invasion should be considered malignant until proven otherwise."
        },
        {
          "id": "cannot_determine",
          "points": 0
        }
      ]
    },
    {
      "id": "echogenic_foci",
      "selection": "choose_all_that_apply",
      "options": [
        {
          "id": "none_or_large_comet_tail",
          "points": 0
        },
        {
          "id": "macrocalcifications",
          "points": 1
        },
        {
          "id": "peripheral_rim_calcifications",
          "points": 2
        },
        {
          "id": "punctate_echogenic_foci",
          "points": 3
        }
      ]
    }
  ],
  "score_operation": "Sum composition, echogenicity, shape, margin, and every applicable echogenic-foci point value.",
  "score_map": [
    {
      "points": "0",
      "outcome_code": "TR1"
    },
    {
      "points": "2",
      "outcome_code": "TR2"
    },
    {
      "points": "3",
      "outcome_code": "TR3"
    },
    {
      "points": "4-6",
      "outcome_code": "TR4"
    },
    {
      "points": ">=7",
      "outcome_code": "TR5"
    }
  ],
  "size_thresholds_mm": {
    "TR1": {
      "fna": "never",
      "follow_up": "none"
    },
    "TR2": {
      "fna": "never",
      "follow_up": "none"
    },
    "TR3": {
      "fna_if_gte": 25,
      "follow_if_gte": 15,
      "follow_if_lt_fna": true,
      "follow_up_years": [
        1,
        3,
        5
      ]
    },
    "TR4": {
      "fna_if_gte": 15,
      "follow_if_gte": 10,
      "follow_if_lt_fna": true,
      "follow_up_years": [
        1,
        2,
        3,
        5
      ]
    },
    "TR5": {
      "fna_if_gte": 10,
      "follow_if_gte": 5,
      "follow_if_lt_fna": true,
      "follow_up_years": [
        1,
        2,
        3,
        4,
        5
      ]
    }
  },
  "interval_change": {
    "significant_growth": ">=20% increase in at least two dimensions with an absolute increase of >=2 mm",
    "consequence": "Reapply the management threshold using the new size for the existing TR level."
  },
  "exceptions": [
    {
      "if": "previously biopsied",
      "then": "TR classification may be reported, but management must incorporate pathology; ACR TI-RADS does not provide a standalone recommendation."
    },
    {
      "if": "focal FDG-PET uptake and size >10 mm in a patient with normal life expectancy",
      "then": "ACR FAQ recommends biopsy regardless of TR category; clinical context may alter this in patients with another malignancy."
    }
  ],
  "source_locator": "ACR TI-RADS Atlas and Assessment Categories chart; ACR Diagnostic Ultrasound Reporting Template; ACR TI-RADS FAQ 111-116."
}

Categorias num relance

Cat.SignificadoCondutaRiscoFonte
TR1
Benign
Total of 0 points across the five ACR TI-RADS feature categories (composition, echogenicity, shape, margin, echogenic foci).
No FNA and no follow-up recommended at any size.Benign category; partial NMD analysis cited in the paper reports cancer risk of no more than 2% for TR1 and TR2 nodules combined.
ACR TI-RADS points table / risk-stratification chart (0 Points = TR1, Benign; "No FNA" row); discussion section ("cancer risk levels of no more than 2% for TR1 and TR2 nodules")
TR2
Not suspicious
Total of 2 points after adding the selected composition, echogenicity, shape, margin, and all applicable echogenic-foci values.
No FNA and no follow-up recommended at any size.Not Suspicious category; partial NMD analysis cited in the paper reports cancer risk of no more than 2% for TR1 and TR2 nodules combined.
ACR TI-RADS points table / chart (2 Points = TR2, Not Suspicious; "No FNA" row); discussion section ("no more than 2% for TR1 and TR2 nodules")
TR3
Mildly suspicious
Total of 3 points after adding the selected composition, echogenicity, shape, margin, and all applicable echogenic-foci values.
FNA when maximum diameter is 2.5 cm or larger. For nodules 1.5-2.4 cm, follow-up ultrasound at 1, 3, and 5 years. No FNA or routine follow-up below 1.5 cm.Mildly Suspicious category; partial NMD analysis cited in the paper reports cancer risk of approximately 5% for TR3 nodules.
ACR TI-RADS Atlas/assessment chart (3 points = TR3; FNA >=2.5 cm; follow >=1.5 cm); ACR Diagnostic Ultrasound Reporting Template, recommendation schedule (follow-up at years 1, 3, and 5); white-paper discussion (approximately 5% risk)
TR4
Moderately suspicious
Total of 4-6 points after adding the selected composition, echogenicity, shape, margin, and all applicable echogenic-foci values.
FNA when maximum diameter is 1.5 cm or larger. For nodules 1.0-1.4 cm, follow-up ultrasound at 1, 2, 3, and 5 years. No FNA or routine follow-up below 1.0 cm.Moderately Suspicious category; partial NMD analysis cited in the paper reports cancer risk of approximately 5% to 20% for TR4 nodules.
ACR TI-RADS Atlas/assessment chart (4-6 points = TR4; FNA >=1.5 cm; follow >=1.0 cm); ACR Diagnostic Ultrasound Reporting Template, recommendation schedule (follow-up at years 1, 2, 3, and 5); white-paper discussion (approximately 5%-20% risk)
TR5
Highly suspicious
Total of 7 points or more after adding the selected composition, echogenicity, shape, margin, and all applicable echogenic-foci values.
FNA when maximum diameter is 1.0 cm or larger. For nodules 0.5-0.9 cm, follow-up ultrasound every year for 5 years. No FNA or routine follow-up below 0.5 cm.Highly Suspicious category; partial NMD analysis cited in the paper reports cancer risk of at least 20% for TR5 nodules.
ACR TI-RADS Atlas/assessment chart (>=7 points = TR5; FNA >=1.0 cm; follow >=0.5 cm); ACR Diagnostic Ultrasound Reporting Template, recommendation schedule (annual follow-up for 5 years); white-paper discussion (at least 20% risk)

Referências cruzadas

fronteira compartilhadaBI-RADS. Breast Imaging Reporting and Data System, 5th editionShares the ACR Reporting and Data System framework that BI-RADS established.
fronteira compartilhadaEU-TIRADS. European Thyroid Imaging Reporting and Data SystemEuropean alternative to ACR TI-RADS for thyroid nodule risk stratification, with different thresholds.

Histórico de versões

DataEventoDetalheSituação
2026-08-11revisedMonitored source changed (content_hash). Detected automatically; awaiting reviewer confirmation. evidênciaaguardando revisão
2026-08-09revisedMonitored source changed (content_hash). Detected automatically; awaiting reviewer confirmation. evidênciaaguardando revisão
2026-08-07revisedMonitored source changed (content_hash). Detected automatically; awaiting reviewer confirmation. evidênciaaguardando revisão
2026-08-06revisedMonitored source changed (content_hash). Detected automatically; awaiting reviewer confirmation. evidênciaaguardando revisão
2026-08-05revisedMonitored source changed (content_hash). Detected automatically; awaiting reviewer confirmation. evidênciaaguardando revisão
2026-08-04revisedMonitored source changed (content_hash). Detected automatically; awaiting reviewer confirmation. evidênciaaguardando revisão
2026-07-31revisedMonitored source changed (content_hash). Detected automatically; awaiting reviewer confirmation. evidênciaaguardando revisão
2026-07-25revisedMonitored source changed (content_hash). Detected automatically; awaiting reviewer confirmation. evidênciaaguardando revisão
2026-07-24revisedMonitored source changed (content_hash). Detected automatically; awaiting reviewer confirmation. evidênciaaguardando revisão
2026-07-23revisedMonitored source changed (content_hash). Detected automatically; awaiting reviewer confirmation. evidênciaaguardando revisão
2026-07-21revisedMonitored source changed (content_hash). Detected automatically; awaiting reviewer confirmation. evidênciaaguardando revisão
2026-07-20revisedMonitored source changed (content_hash). Detected automatically; awaiting reviewer confirmation. evidênciaaguardando revisão
2026-07-19revisedMonitored source changed (content_hash). Detected automatically; awaiting reviewer confirmation. evidênciaaguardando revisão
2026-07-18revisedMonitored source changed (content_hash). Detected automatically; awaiting reviewer confirmation. evidênciaaguardando revisão
2026-07-17revisedMonitored source changed (content_hash). Detected automatically; awaiting reviewer confirmation. evidênciaaguardando revisão
2026-07-16revisedMonitored source changed (content_hash). Detected automatically; awaiting reviewer confirmation. evidênciaaguardando revisão
2026-07-15revisedMonitored source changed (content_hash). Detected automatically; awaiting reviewer confirmation. evidênciaaguardando revisão
2026-07-10revisedMonitored source changed (content_hash). Detected automatically; awaiting reviewer confirmation. evidênciaaguardando revisão
2026-07-08revisedMonitored source changed (content_hash). Detected automatically; awaiting reviewer confirmation. evidênciaaguardando revisão
2026-07-07revisedMonitored source changed (content_hash). Detected automatically; awaiting reviewer confirmation. evidênciaaguardando revisão
2026-07-05revisedMonitored source changed (content_hash). Detected automatically; awaiting reviewer confirmation. evidênciaaguardando revisão
2026-06-30revisedMonitored source changed (content_hash). Detected automatically; awaiting reviewer confirmation. evidênciaaguardando revisão
2026-06-29revisedMonitored source changed (content_hash). Detected automatically; awaiting reviewer confirmation. evidênciaaguardando revisão
2026-06-25revisedMonitored source changed (content_hash). Detected automatically; awaiting reviewer confirmation. evidênciaaguardando revisão
2026-06-24revisedMonitored source changed (content_hash). Detected automatically; awaiting reviewer confirmation. evidênciaaguardando revisão
2017-05-01publishedACR TI-RADS white paper published in JACR. evidênciaconfirmado
Quickstart da APIGET /api/v1/systems/ti-rads-2017aberto
curl -s "https://radcommons.laudos.ai/api/v1/systems/ti-rads-2017"
Ver documentação completa